5 天之前 · TOKYO and BOSTON -- February 7, 2025 – Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi …

4 天之前 · Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corpo. Bain Capital, a leading …

1 天前 · Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) from Mitsubishi Chemical Group …

2 天之前 · Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking boom in Japan. The deal values Mitsubishi …

4 天之前 · Following rumblings of a private equity bidding war late last year, Bain Capital has emerged triumphant on its quest to obtain Japanese drugmaker Mitsubishi Tanabe Pharma. …

4 天之前 · Bain Capital has placed a $3.3bn bet on a historic shift in Japan’s conservative drugs approval regime by buying a pharmaceutical company founded more than three centuries ago. …

4 天之前 · The U.S. investment company said Friday that it will buy Mitsubishi Tanabe Pharma for about 510 billion yen, equivalent to $3.37 billion. ... Supported by Bain Capital, Tanabe plans …

1 天前 · Bain Capital on Friday dropped $3.3 billion to acquire Mitsubishi Tanabe Pharma Corporation in a carve-out deal, giving the investment firm access to the Japanese life …

5 天之前 · Bain Capital’s buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and …

5 天之前 · TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi …